SCHEMBL473960

SCHEMBL473960

CC(c1ccc(-c2ccc(F)cc2)cc1Cl)C(O)(c1cccc(C#N)c1)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AR P10275 3/20 0.41
NR3C1 P04150 3/20 0.39
HSD11B1 P28845 4/20 0.39
PTPN5 P54829 2/20 0.38
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
MCHR1 Q99705 2/20 0.35
CYP17A1 P05093 1/20 0.35
CYP3A4 P08684 1/20 0.35
NR1H3 Q13133 1/20 0.34
NR1H2 P55055 1/20 0.33
PDK1 Q15118 1/20 0.33
PDK2 Q15119 1/20 0.33
PDK3 Q15120 1/20 0.33
PDK4 Q16654 1/20 0.33
NR3C2 P08235 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL473957 0.93 AR (0.41) ARNR3C1HSD11B1PTPN5GABRG2
SCHEMBL473901 0.88 HSD11B1 (0.47) ARHSD11B1PTPN5
SCHEMBL474109 0.86 XDH (0.38) ARHSD11B1PTPN5MCHR1NR1H2
SCHEMBL12164143 0.86 XDH (0.38) ARHSD11B1PTPN5MCHR1NR1H2
SCHEMBL473940 0.86 XDH (0.40) ARHSD11B1PTPN5MCHR1NR1H3
SCHEMBL12164149 0.86 XDH (0.40) ARHSD11B1PTPN5MCHR1NR1H3
SCHEMBL15520405 0.84 PTGDR2 (0.39) ARHSD11B1PTPN5MCHR1NR1H2
SCHEMBL15520242 0.83 PTGDR2 (0.37) ARHSD11B1PTPN5MCHR1NR1H2
SCHEMBL474038 0.83 HSD11B1 (0.43) ARHSD11B1PTPN5GABRG2GABRB3
SCHEMBL473894 0.74 HSD11B1 (0.43) ARHSD11B1PDK1PDK2PDK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411365-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP claimed
EP-2411365-A1 2,3-DIARYL- OR HETEROARYL-SUBSTITUTED 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2012-02-01 EP disclosed